Roderick Wong
Insider Reports History
- Location
- New York, NY
- Signature
- /s/ Martin Wilson, as attorney-in-fact for Roderick Wong
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by Roderick Wong:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ROCKET PHARMACEUTICALS, INC. | Director, 10%+ Owner | Common Stock | 18,188,457 | $44,572,632 | $2.45 | 18 Jun 2025 | Indirect |
| ROCKET PHARMACEUTICALS, INC. | Director, 10%+ Owner | Common Stock | 47,667 | $116,812 | $2.45 | 18 Jun 2025 | Direct |
| Avidity Biosciences, Inc. | Director, 10%+ Owner | Stock Option (Right to Buy) | 15,000 | 16 Jun 2021 | Direct |
Insider Reports Filed by Roderick Wong
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| RCKT | ROCKET PHARMACEUTICALS, INC. | 18 Jun 2025 | 2 | $0 | 4 | Director, 10%+ Owner | 18 Jul 2025, 16:05 |
| RCKT | ROCKET PHARMACEUTICALS, INC. | 13 Jun 2024 | 2 | +$50,008 | 4 | Director, 10%+ Owner | 20 Jun 2024, 16:10 |
| RCKT | ROCKET PHARMACEUTICALS, INC. | 22 Jun 2023 | 2 | +$50,009 | 4 | Director, 10%+ Owner | 26 Jun 2023, 19:48 |
| OBIO | Health Sciences Acquisitions Corp 2 | 24 Jan 2023 | 1 | +$18,085,120 | 4 | Chief Executive Officer, Director, 10%+ Owner | 26 Jan 2023, 16:23 |
| OBIO | Health Sciences Acquisitions Corp 2 | 22 Jul 2022 | 1 | +$10,010,000 | 4 | Chief Executive Officer, Director | 25 Jul 2022, 08:45 |
| RCKT | ROCKET PHARMACEUTICALS, INC. | 13 Jun 2022 | 2 | +$39,957 | 4 | Director, 10%+ Owner | 15 Jun 2022, 21:07 |
| RCKT | ROCKET PHARMACEUTICALS, INC. | 27 Aug 2021 | 1 | +$26,390,520 | 4 | Director, 10%+ Owner | 31 Aug 2021, 19:11 |
| RNA | Avidity Biosciences, Inc. | 16 Jun 2021 | 1 | $0 | 4 | Director, 10%+ Owner | 17 Jun 2021, 12:53 |
| RCKT | ROCKET PHARMACEUTICALS, INC. | 14 Jun 2021 | 1 | $0 | 4 | Director, 10%+ Owner | 16 Jun 2021, 20:06 |